Boston Scientific (BSX) Land & Improvements (2025 - 2026)
Boston Scientific recorded quarterly Land & Improvements of $188.0 million in Q1 2026, up 8.67% quarter-over-quarter from $173.0 million in Q4 2025.
Boston Scientific's Land & Improvements history runs 2 years deep, the most recent figure standing at $188.0 million for Q1 2026.
- In Q1 2026, Land & Improvements changed N/A year-over-year to $188.0 million; the TTM figure through Mar 2026 stood at $188.0 million (changed N/A YoY), while the FY2025 annual figure was $173.0 million, changed N/A from the prior year.
- Land & Improvements came in at $188.0 million for Q1 2026 at Boston Scientific, up from $173.0 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $188.0 million in Q1 2026 to a low of $173.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 112.30 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.00 Mn |
| Dec 31, 2025 | 173.00 Mn |